Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001548 · ClinicalTrials.gov registry record
Genetics of Obsessive-Compulsive Disorder
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,067
- Enrollment target
NCT00001548: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00001548 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,067 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001548 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,067 participants
- Enrollment target
Study Summary
The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition develops and ultimately improve treatment for people with OCD. OCD is a severe, familial condition that affects approximately 2% of the population. The way OCD is inherited is not clearly understood, but researchers believe it is complex and involves multiple genes. This study will detect and localize genes that increase or decrease susceptibility to OCD. The data collected from this study will be combined with data from other research studies to determine gene linkage and association.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,067 participants |
| Start Date | 1996-08-22 |
| Est. Completion | 2015-09-29 |
What the finished NCT00001548 record still lists
NCT00001548 is an observational study that tracks outcomes without assigning an intervention. Its 1,067 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001548 about?
NCT00001548 is a clinical study titled "Genetics of Obsessive-Compulsive Disorder". The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition develops and ultimately improve treatment for people with OCD. OCD is...
What is the current status of trial NCT00001548?
This trial is currently completed. The enrollment target is 1,067 participants. The study started on 1996-08-22. Estimated completion is 2015-09-29.
Who is sponsoring clinical trial NCT00001548?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI